Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the danish multidisciplinary cancer groups

Radiotherapy (RT) is widely used in the adjuvant and curative treatment of thoracic cancers such as mediastinal lymphoma, breast, lung and esophageal cancer, to improve overall survival. However, thoracic RT may cause incidental RT dose to the heart with a subsequent risk of radiation associated heart disease [1 –3]. For both breast cancer and Hodgkin lymphoma patients, a linear dose-response relationship between mean heart dose (MHD) and the risk of heart disease has been demonstrated [4–6].

Source: Radiotherapy and Oncology - June 12, 2020 Category: Radiology Authors: Marie Louise Holm Milo, Birgitte Vrou Offersen, Troels Bechmann, Axel Cosmus Pyndt Diederichsen, Christian R ønn Hansen, Eva Holtved, Mirjana Josipovic, Tamás Lörincz, Maja Vestmø Maraldo, Mette Holck Nielsen, Marianne Nordsmark, Petra Witt Nyström, Tags: Original Article Source Type: research